Production and Characterization of a Single-Chain Fv Antibody–Alkaline Phosphatase Fusion Protein Specific for Clenbuterol

被引:2
作者
Xixia Liu
Hong Wang
Yan Liang
Jinyi Yang
Hongbin Zhang
Hongtao Lei
Yudong Shen
Yuanming Sun
机构
[1] South China Agricultural University,Key Laboratory of Food Quality and Safety of Guangdong Province, College of Food Science
[2] Guangzhou General Hospital of Guangzhou Military Command,Department of Medical Research
来源
Molecular Biotechnology | 2010年 / 45卷
关键词
Clenbuterol; Single-chain Fv antibody; Bacterial alkaline phosphatase; Fusion protein; ELISA;
D O I
暂无
中图分类号
学科分类号
摘要
The production and characterization of an anti-clenbuterol single-chain Fv antibody (CBLscFv)–bacterial alkaline phosphatase (AP) fusion protein are described. The CBLscFv and the phoA gene of Escherichia coli strain K12 chromosomal DNA were cloned by PCR and sequentially inserted into the expression vector pBV220 to express the CBLscFv–AP fusion protein in E. coli strain BL21(DE3)pLysS. SDS–PAGE and western blot analyses revealed that the fusion protein showed a molecular weight of 73 kDa and bound with the antibacterial AP monoclonal antibody. Determination of enzymatic activity indicated that kcat and Km values of the fusion protein were 113.60 s−1 and 29.82 μM, respectively. Competitive direct enzyme-linked immunosorbent assay based on the obtained fusion protein indicated that the average concentration required for 50% inhibition of binding (IC50) and the limit of detection for CBL were 4.74 ± 0.003 (n = 3) and 0.54 ± 0.004 (n = 3) μg/l, respectively, and the linear response range extended from 1.13 to 69.68 μg/l. Cross-reactivity studies showed that the fusion protein did not cross-react with CBL analogs. The present findings indicate that the production of the CBLscFv–AP fusion protein in E. coli strain BL21(DE3)pLysS is feasible and suggest that it could be further used to develop a one-step ELISA for the specific detection of CBL.
引用
收藏
页码:56 / 64
页数:8
相关论文
共 167 条
[1]  
Guy PA(1999)Quantitative analysis of clenbuterol in meat products using liquid chromatography-electrospray ionisation tandem mass spectrometry Journal of Chromatography B 736 209-219
[2]  
Savoy MC(2005)Determination of clenbuterol, ractopamine and zilpaterol in liver and urine by liquid chromatography tandem mass spectrometry Analytica Chimica Acta 529 199-205
[3]  
Stadler RH(2007)Three-phase solvent bar microextraction and determination of trace amounts of clenbuterol in human urine by liquid chromatography and electrospray tandem mass spectrometry Talanta 72 373-377
[4]  
Blanca J(2002)Determination of clenbuterol in human urine by GC–MS–MS–MS: Confirmation analysis in antidoping control Journal of Chromatography B 773 7-16
[5]  
Munoz P(2002)Diagnostic evidence for the presence of β-agonists using two consecutive derivatization procedures and gas chromatography–mass spectrometric analysis Journal of Chromatography B 780 61-71
[6]  
Morgado M(2003)Clenbuterol food poisoning diagnosis by gas chromatography–mass spectrometric serum analysis Analytica Chimica Acta 483 207-213
[7]  
Mendez N(2004)Three-way models and detection capability of a gas chromatography–mass spectrometry method for the determination of clenbuterol in several biological matrices: The 2002/657/EC European Decision Analytica Chimica Acta 515 55-63
[8]  
Aranda A(2007)Determination of ractopamine and clenbuterol in feeds by gas chromatography–mass spectrometry Animal Feed Science and Technology 132 316-323
[9]  
Reuvers T(2006)Determination of clenbuterol by capillary electrophoresis immunoassay with chemiluminescence detection Talanta 70 353-357
[10]  
Hooghuis H(2006)Field-amplified on-line sample stacking for separation and determination of cimaterol, clenbuterol and salbutamol using capillary electrophoresis Journal of Chromatography A 1125 124-128